Abbott Laboratories Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 278 trades in Abbott Laboratories (NYSE: ABT) since 2013, across 53 members, worth an estimated $7.4M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 147 buys against 129 sells, a modestly buy-led skew, with Democratic members responsible for 49% of the trades and Republican members 51%. The most recent disclosure shown was filed June 2026, and Ro Khanna has filed the most ABT transactions among those shown, with 13. Other recent filers include Josh Gottheimer, Gilbert Cisneros, and Richard W. Allen. One notable disclosed move was a purchase by Lisa Mcclain on June 24, 2025, down 34.8% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Abbott Laboratories's current Bullish Whales Tide Score is 58 out of 100 (Mid Tide), Top 12% of universe (87); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Abbott Laboratories (ABT) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Abbott Laboratories congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Josh Gottheimer House | Jun 3, 2026 | May 27, 2026 | 7 days | SELL |  $1,001 - $15,000 | +2.92% | |
 Gilbert Cisneros House | Jun 8, 2026 | May 15, 2026 | 24 days | SELL | $1,001 - $15,000 | +4.39% | |
 Richard W. Allen House | Jun 5, 2026 | Apr 16, 2026 | 50 days | SELL | $15,001 - $50,000 | -7.64% | |
 Ro Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL | $15,001 - $50,000 | -12.90% | |
 Laura Friedman House | Apr 17, 2026 | Mar 24, 2026 | 24 days | BUY | $1,001 - $15,000 | -14.73% | |
Laura Friedman House | Apr 17, 2026 | Mar 24, 2026 | 24 days | BUY | $1,001 - $15,000 | -14.73% | |
Ro Khanna House | Apr 7, 2026 | Mar 23, 2026 | 15 days | BUY | $15,001 - $50,000 | -15.37% | |
| Apr 7, 2026 | Mar 19, 2026 | 19 days | BUY | $1,001 - $15,000 | -17.22% | ||
| Apr 7, 2026 | Mar 19, 2026 | 19 days | BUY | $1,001 - $15,000 | -17.22% | ||
Ro Khanna House | Apr 7, 2026 | Mar 10, 2026 | 28 days | BUY | $1,001 - $15,000 | -19.73% |
Abbott Laboratories (ABT) congressional trading FAQ
Can members of Congress legally trade Abbott Laboratories (ABT) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Abbott Laboratories (ABT) trades public?
Yes. Every congressional trade in Abbott Laboratories (ABT) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Abbott Laboratories (ABT)?
Members of Congress have disclosed 278 trades in Abbott Laboratories (ABT) worth $7.4M across 53 members, according to public STOCK Act filings.
Which members of Congress have traded Abbott Laboratories (ABT)?
Recent and active filers of Abbott Laboratories (ABT) disclosures include Ro Khanna, Michael T. McCaul, Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Abbott Laboratories (ABT) more?
Across disclosed Abbott Laboratories (ABT) trades, 49% were by Democrats and 51% by Republicans, led by Republicans (51%).
What is the most recent congressional Abbott Laboratories (ABT) trade?
The most recent disclosed Abbott Laboratories (ABT) trade was a sale by Gilbert Cisneros, filed Jun 7, 2026.
What is Abbott Laboratories (ABT)'s Tide Score?
Abbott Laboratories (ABT) has a BullishWhales Tide Score of 58 (Mid Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewAbbott Laboratories (ABT) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.